Billion To One

LEADERSHIP
Oguzhan Atay, PhD and David Tsao, PhD
Molecular counting platform to help quantify nearly undetectable DNA changes, unlocking improvements to non-invasive prenatal screening and liquid biopsy.
SECTOR(S)
Healthcare
INVEStMENT STAGE
Growth
STATUS
IPO/Public